Hong Kong unveils first 5-year plan targeting biomedicine hub status

Hong Kong will include biomedicine in its first five-year plan, signaling a strategic push to become a regional biotech hub. GSK's interest at BIOHK underscores growing corporate engagement, though concrete policy details remain pending. This marks a notable policy shift for Hong Kong, aligning with Greater Bay Area integration.